… Risk scoring systems for MDS prognostication were traditionally based on karyotype … , and
validation was typically conducted on de novo MDS patients. However, retrospective analysis …

… for the classification of the myelodysplastic syndromes. Br J Haematol … C: Validation of the
WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective …

… Risk models in MDS are constructed by incorporating several validated prognostic
variables … In a retrospective review among 600 patients, investigators applied the adult co-morbidity …

… Using a retrospective case-control study design, we found that the intra-individual robust
coefficient of variation (RCV) for peripheral blood neutrophil myeloperoxidase expression …

… in the specific context of myelodysplastic syndromes (MDS). We … We conducted a multicentre
retrospective cohort study. … All the statistical analyses were discussed and validated by a …

… We retrospectively reviewed clinical and pathological data of 253 patients with hypocellular
… that warrants further validation in a larger cohort of patients with hypocellular MDS, ideally in …

… different independent cohorts of patients in both retrospective 7 and prospective 8 studies, …
analyzed 1,915 patients to propose and validate a new risk model for MDS. This model (MD …

… The LR-MDAS model was also validated by us in 1,288 LR-MDS patients using the IPSS. …
Despite being limited by the retrospective design, our study provides important conclusions …

… We conducted a retrospective cohort study among patients with IBD from Veteran Affairs …
To include only validated outcome events, we searched for patients with relevant ICD codes …

… the natural history of myelodysplastic syndrome with the aim … with myelodysplastic syndrome
in Pavia, Italy, and a validation … Although the retrospective nature of the analysis implies that …